About

Nancy R. Phelan has served as an Achieve Life Sciences director since 2025 and serves on the Audit and Commercial Committees. She is Senior Vice President of Marketing and Analytics for Phathom Pharmaceuticals, Inc. and previously served as Senior Vice President and Head of Customer Engagement at Trinity Life Sciences and Senior Vice President of Indegene. Earlier she held roles of increasing responsibility at Novartis AG, and served as Chief Executive Officer and a director of Adhera Therapeutics. She is a director of Medexus Pharmaceuticals (since 2023). Ms. Phelan received a B.A. with Honors from Franklin & Marshall College and completed coursework toward an M.B.A. from Villanova University, with certificates from Wharton Executive Education and the Harvard School of Public Health.

Roles

Achieve Life Sciences, Inc.
Director · Current role
2025–present
Phathom Pharmaceuticals, Inc.
SVP of Marketing and Analytics
present
Trinity Life Sciences
SVP and Head of Customer Engagement
Indegene
Senior Vice President
2022 - 2024
Novartis AG
VP, Business Transformation / VP, Patient and Specialty Services
2002 - 2022
Adhera Therapeutics, Inc.
Chief Executive Officer and Director
2018 - 2020

External Roles

Medexus Pharmaceuticals
Director
2023 - present

Director Compensation

FY 2025
Fees earned or paid in cash
$50,417
ComponentNon-employee director cash retainers and fees earned in FY2025 (partial year; joined January 2025)
Option awards
$190,845
ComponentInitial and annual director stock-option grants, ASC 718 grant-date fair value
Total
$241,262

Also at Achieve Life Sciences, Inc.

Related

See how VectorShift works for your firm

Request Demo